Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
2.110
-0.030 (-1.40%)
At close: Sep 17, 2025, 4:00 PM EDT
2.110
0.00 (0.00%)
After-hours: Sep 17, 2025, 7:52 PM EDT
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $3.79 million as of September 17, 2025. Its market cap has increased by 48.08% in one year.
Market Cap
3.79M
Enterprise Value
-2.85M
1-Year Change
48.08%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $3.79M, a decrease of -97.57%. That is a compound annual growth rate of -32.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 3.84M | 65.85% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.15B |
| Johnson & Johnson | 427.84B |
| AbbVie | 381.26B |
| UnitedHealth Group | 315.67B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.02B |